LipidLaunch(TM) MC3 LNP (GFP)

LipidLaunch(TM) MC3 LNP (GFP) is a solution containing lipid nanoparticles (LNPs) composed of the ionizable cationic amino lipid DLin-MC3-DMA (MC3, Cay-34364), cholesterol (Cay-9003100, Cay-39088), the phospholipid 1,2-distearoyl-sn-glycero-3-PC (Cay-15100, Cay-39189), and the lipid excipient DMG-PEG(2000) (Cay-33945) at a molar ratio of 50:38.5:10:1.5 and encapsulating mRNA encoding the fluorescent protein GFP. It is intended for proof-of-concept experiments to determine whether MC3-based LNPs can effectively lead to expression of a protein of interest in a target cell type, either in vitro or in vivo. GFP has excitation/emission maxima of 488/507 nm, respectively. Suggested in vitro use: Thaw LNPs on ice with occasional gentle swirling (do not vortex). Using a gentle pipetting technique, dilute 1:100-1:500 in complete cell culture media (with serum) and add to subconfluent adherent cells in a fluorescence imaging-compatible tissue culture plate. Expression of GFP may be detectable as early as six hours after treatment. Optimal conditions are highly dependent on cell type.Synonyms: LipidLaunch(TM) DLin-MC3-DMA LNP. Emission: 507 nm. Excitation: 488 nm. Formulation: (Request formulation change), TBS, pH 7.5, with 10% sucrose.